三星医疗 内部交易概览
暂无关于该公司的高管股东内部交易数据
暂无关于该公司18月以内的内部交易数据
三星医疗 内部交易
三星医疗 最新内部交易
郑坚江 | 董事 | 2022-02-25 | - | 28,000,000 | 179,306,730 |
¥11.61
|
+191.65%
|
沈国英 | Directors, senior managers | 2022-01-13 | - | 650,000 | 650,000 |
¥7.8
|
+334.10%
|
郭粟 | Directors, senior managers | 2022-01-13 | - | 600,000 | 600,000 |
¥7.8
|
+334.10%
|
郑君达 | Supervisors | 2022-01-05 | - | 180,000 | 547,375 |
¥15.62
|
+116.77%
|
郑君达 | Supervisors | 2021-11-08 | - | 240,000 | 727,375 |
¥12.37
|
+173.73%
|
缪锡雷 | Directors, senior managers | 2020-11-10 | - | 256,000 | 769,000 |
¥7.82
|
+332.99%
|
缪锡雷 | Directors, senior managers | 2020-11-10 | - | 256,000 | 769,000 |
¥7.82
|
+332.99%
|
郑坚江 | 董事 | 2020-09-24 | - | 27,730,000 | 207,306,730 |
¥6.27
|
+440.03%
|
郑坚江 | 董事 | 2020-09-24 | - | 27,730,000 | 207,306,730 |
¥6.27
|
+440.03%
|
忻宁 | 董事 | 2018-11-21 | - | 530,000 | 700,000 |
¥4.97
|
+581.29%
|